Cargando…

Oxidative stress tolerance of early stage diabetic endothelial progenitor cell

INTRODUCTION: One of the causes for poor vasculogenesis of diabetes mellitus (DM) is known to rise from the dysfunction of bone marrow-derived endothelial progenitor cells (BM EPCs). However, the origin of its cause is less understood. We aimed to investigate the effect of oxidative stress in early...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukmawati, Dewi, Fujimura, Satoshi, Jitsukawa, Sachie, Ito-Hirano, Rie, Ishii, Takamasa, Sato, Tadayuki, Hayashi, Ayato, Itoh, Seigo, Mizuno, Hiroshi, Daida, Hiroyuki, Tanaka, Rica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581786/
https://www.ncbi.nlm.nih.gov/pubmed/31245440
http://dx.doi.org/10.1016/j.reth.2014.11.001
_version_ 1783428212392460288
author Sukmawati, Dewi
Fujimura, Satoshi
Jitsukawa, Sachie
Ito-Hirano, Rie
Ishii, Takamasa
Sato, Tadayuki
Hayashi, Ayato
Itoh, Seigo
Mizuno, Hiroshi
Daida, Hiroyuki
Tanaka, Rica
author_facet Sukmawati, Dewi
Fujimura, Satoshi
Jitsukawa, Sachie
Ito-Hirano, Rie
Ishii, Takamasa
Sato, Tadayuki
Hayashi, Ayato
Itoh, Seigo
Mizuno, Hiroshi
Daida, Hiroyuki
Tanaka, Rica
author_sort Sukmawati, Dewi
collection PubMed
description INTRODUCTION: One of the causes for poor vasculogenesis of diabetes mellitus (DM) is known to rise from the dysfunction of bone marrow-derived endothelial progenitor cells (BM EPCs). However, the origin of its cause is less understood. We aimed to investigate the effect of oxidative stress in early stage of diabetic BM-EPC and whether its vasculogenic dysfunction is caused by oxidative stress. METHODS: Bone marrow c-Kit+Sca-1+Lin− (BM-KSL) cells were sorted from control and streptozotocin-induced diabetic C57BL6J mice by flow cytometry. BM-KSLs were then assessed for vasculogenic potential (colony forming assay; EPC-CFA), accumulation of intracellular ROS (CM-H2DCFDA), carbonylated protein (ELISA), anti-oxidative enzymes expression (RT-qPCR) and catalase activity (Amplex Red). RESULTS: Compared to control, DM BM-KSL had significantly lower EPC-CFUs in both definitive EPC-CFU and total EPC-CFU (p < 0.05). Interestingly, the oxidative stress level of DM BM-KSL was comparable and was not significantly different to control followed by increased in anti-oxidative enzymes expression and catalase activity. CONCLUSIONS: Primitive BM-EPCs showed vasculogenic dysfunction in early diabetes. However the oxidative stress is not denoted as the major initiating factor of its cause. Our results suggest that primitive BM-KSL cell has the ability to compensate oxidative stress levels in early diabetes by increasing the expression of anti-oxidative enzymes.
format Online
Article
Text
id pubmed-6581786
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Japanese Society for Regenerative Medicine
record_format MEDLINE/PubMed
spelling pubmed-65817862019-06-26 Oxidative stress tolerance of early stage diabetic endothelial progenitor cell Sukmawati, Dewi Fujimura, Satoshi Jitsukawa, Sachie Ito-Hirano, Rie Ishii, Takamasa Sato, Tadayuki Hayashi, Ayato Itoh, Seigo Mizuno, Hiroshi Daida, Hiroyuki Tanaka, Rica Regen Ther Original Article INTRODUCTION: One of the causes for poor vasculogenesis of diabetes mellitus (DM) is known to rise from the dysfunction of bone marrow-derived endothelial progenitor cells (BM EPCs). However, the origin of its cause is less understood. We aimed to investigate the effect of oxidative stress in early stage of diabetic BM-EPC and whether its vasculogenic dysfunction is caused by oxidative stress. METHODS: Bone marrow c-Kit+Sca-1+Lin− (BM-KSL) cells were sorted from control and streptozotocin-induced diabetic C57BL6J mice by flow cytometry. BM-KSLs were then assessed for vasculogenic potential (colony forming assay; EPC-CFA), accumulation of intracellular ROS (CM-H2DCFDA), carbonylated protein (ELISA), anti-oxidative enzymes expression (RT-qPCR) and catalase activity (Amplex Red). RESULTS: Compared to control, DM BM-KSL had significantly lower EPC-CFUs in both definitive EPC-CFU and total EPC-CFU (p < 0.05). Interestingly, the oxidative stress level of DM BM-KSL was comparable and was not significantly different to control followed by increased in anti-oxidative enzymes expression and catalase activity. CONCLUSIONS: Primitive BM-EPCs showed vasculogenic dysfunction in early diabetes. However the oxidative stress is not denoted as the major initiating factor of its cause. Our results suggest that primitive BM-KSL cell has the ability to compensate oxidative stress levels in early diabetes by increasing the expression of anti-oxidative enzymes. Japanese Society for Regenerative Medicine 2015-02-23 /pmc/articles/PMC6581786/ /pubmed/31245440 http://dx.doi.org/10.1016/j.reth.2014.11.001 Text en © 2015, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Sukmawati, Dewi
Fujimura, Satoshi
Jitsukawa, Sachie
Ito-Hirano, Rie
Ishii, Takamasa
Sato, Tadayuki
Hayashi, Ayato
Itoh, Seigo
Mizuno, Hiroshi
Daida, Hiroyuki
Tanaka, Rica
Oxidative stress tolerance of early stage diabetic endothelial progenitor cell
title Oxidative stress tolerance of early stage diabetic endothelial progenitor cell
title_full Oxidative stress tolerance of early stage diabetic endothelial progenitor cell
title_fullStr Oxidative stress tolerance of early stage diabetic endothelial progenitor cell
title_full_unstemmed Oxidative stress tolerance of early stage diabetic endothelial progenitor cell
title_short Oxidative stress tolerance of early stage diabetic endothelial progenitor cell
title_sort oxidative stress tolerance of early stage diabetic endothelial progenitor cell
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581786/
https://www.ncbi.nlm.nih.gov/pubmed/31245440
http://dx.doi.org/10.1016/j.reth.2014.11.001
work_keys_str_mv AT sukmawatidewi oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell
AT fujimurasatoshi oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell
AT jitsukawasachie oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell
AT itohiranorie oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell
AT ishiitakamasa oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell
AT satotadayuki oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell
AT hayashiayato oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell
AT itohseigo oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell
AT mizunohiroshi oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell
AT daidahiroyuki oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell
AT tanakarica oxidativestresstoleranceofearlystagediabeticendothelialprogenitorcell